To confirm that IER3 was expressed in CAFs, we used antibodies against IER3 and collagen type III α 1 chain (COL3A1, a marker of fibroblast) to stain a subset of tumor specimens from cohort 3 (19 samples from 11 patients, Figure 7a). This evidence concerns the gene COL3A1 and neoplasm.